Court ruling ends pharma challenge to Medicare drug price talks

The Fifth Circuit Court of Appeals rejected the pharmaceutical industry's lawsuit against Medicare's drug price negotiation program. This decision marks a definitive legal defeat for the trade group that brought the challenge. The ruling effectively upholds the government's ability to negotiate prices for certain high-cost medications.